DEXCOM INC — Director's Dealing 2020

Sep 16, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2020-09-14

Reporting Person: FOLETTA MARK G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-09-14	Common Stock	S	3	$386.21	Disposed	16199	Indirect
2020-09-14	Common Stock	S	109	$390.858	Disposed	16090	Indirect
2020-09-14	Common Stock	S	200	$391.9484	Disposed	15890	Indirect
2020-09-14	Common Stock	S	231	$393.7281	Disposed	15659	Indirect
2020-09-14	Common Stock	S	222	$395.2821	Disposed	15437	Indirect
2020-09-14	Common Stock	S	121	$396.1669	Disposed	15316	Indirect
2020-09-14	Common Stock	S	114	$397.7518	Disposed	15202	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	895	Direct

Footnotes

F1: On June 6, 2020, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee.

F3: This transaction was executed in multiple trades at prices ranging from $390.475 to $391.08. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F4: This transaction was executed in multiple trades at prices ranging from $391.585 to $392.745. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F5: This transaction was executed in multiple trades at prices ranging from $393.41 to $394.11. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F6: This transaction was executed in multiple trades at prices ranging from $394.78 to $395.635. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F7: This transaction was executed in multiple trades at prices ranging from $395.795 to $396.47. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F8: This transaction was executed in multiple trades at prices ranging from $397.385 to $397.95. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.